WCN24-943 CASE REPORT: CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENT DEVELOPED PROGRESSIVE CHRONIC KIDNEY DISEASE CAUSED BY LYSOZYME-INDUCED NEPHROPATHY

WCN24-943 CASE REPORT: CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENT DEVELOPED PROGRESSIVE CHRONIC KIDNEY DISEASE CAUSED BY LYSOZYME-INDUCED NEPHROPATHY

Saved in:

Bibliographic Details
Main Authors:	Isis De Vito Izzo Ferreira, Lucas Antonio Oliveira Faria, Felipe Lourenço Ledesma, Tassila Gomes Maia, João Paulo Senna Ferreira, Cristiane Bitencourt Dias, Lecticia Barbosa Jorge, Irene de Lourdes Noronha, Luis Yu
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924013986
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A case of chronic myelomonocytic related lysozyme-induced nephropathy
by: Abhik Kansal, et al.
Published: (2025-07-01)

AKI in chronic myeloid leukemia: remember lysozyme-induced nephropathy
by: Adriana Santos, et al.
Published: (2025-03-01)

Re‐evaluation of butane (E 943a), isobutane (E 943b) and propane (E 944) as food additives
by: EFSA Panel on Food Additives and Flavourings (FAF), et al.
Published: (2025-01-01)

Chronic myelomonocytic leukemia: A case report
by: Khevna Kansara, et al.
Published: (2024-10-01)

Chronic Myelomonocytic Leukemia Associated With TAFRO Syndrome-Like Symptoms
by: Issam Drici-Tani, et al.
Published: (2024-05-01)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
by: Peter Rohon, et al.
Published: (2012-01-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Marianna Criscuolo, et al.
Published: (2011-01-01)

Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia
by: Ann Miller, et al.
Published: (2018-01-01)

5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature
by: Mariangela Greco, et al.
Published: (2011-03-01)

A Case of Acquired Haemophilia A in a Patient with Chronic Myelomonocytic Leukaemia
by: Takeshi Araki, et al.
Published: (2019-01-01)

Dacogen administration experience for treatment of patients with myelodisplastic syndrome and chronic myelomonocytic leukemia
by: S. V. Gritzaev, et al.
Published: (2022-11-01)

Unusual transformation from refractory anemia to chronic myelomonocytic leukemia: a case report.
by: Pasquale Niscola
Published: (2014-08-01)

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)

Risk factors of incomplete balloon-assisted enteroscopy with an analysis of 943 patients: a retrospective study
by: Jun Liu, et al.
Published: (2025-07-01)

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations
by: Yang Zhang, et al.
Published: (2025-08-01)

Beyond the Ordinary: An Unusual Case of Chronic Myelomonocytic Leukemia with Homogeneously Staining Regions in 11q
by: Syeda Ambareen Zehra, et al.
Published: (2025-01-01)

Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)
by: Anthony Crymes, et al.
Published: (2024-01-01)

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
by: Li-Hong Shou, et al.
Published: (2017-01-01)

Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia
by: Bradley Rockwell, et al.
Published: (2025-07-01)

Caught in the crossfire: a case of splenic infarction amid G-CSF therapy in chronic myelomonocytic leukaemia
by: Supriya Peshin, et al.
Published: (2025-02-01)

LYSOZYME-INDUCED NEPHROPATHY IN CMML: A RARE BUT SIGNIFICANT COMPLICATION REQUIRING EARLY RECOGNITION AND INTERVENTION
by: Alfadil Haroon, et al.
Published: (2025-07-01)

Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways
by: Donia Hidaoui, et al.
Published: (2024-11-01)

Integrating multi-omics methods for personalized treatment of refractory chronic myelomonocytic leukemia with NRAS and TET2 mutations
by: Chuandong Hou, et al.
Published: (2025-03-01)

Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report
by: Grace S. Park, et al.
Published: (2025-01-01)

Diagnostic and taxonomic challenges in chronic myelomonocytic leukemia with lymph node involvement: A case report and mini-review
by: Bhaumik Shah, et al.
Published: (2025-01-01)

Prognostic Significance and Treatment Response Associations of Genetic Mutations in Chronic Myelomonocytic Leukemia: A Retrospective Cohort Study
by: Jing Di, et al.
Published: (2024-10-01)

Bactericidal Effect of Lysozyme
by: V. M. Podboronov, et al.
Published: (2020-05-01)

CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
by: Kelly Lim, et al.
Published: (2024-01-01)

Lysozyme-Imprinted Surface Plasmon Resonance Chips Decorated with Gold Nanoparticles for Lysozyme Detection
by: Şeyma Eriş, et al.
Published: (2025-06-01)

Cryopyrin-Associated Periodic Syndrome (CAPS) Caused by c.943A>G Variant of NLRP3 Gene: Clinical Case
by: Ivan A. Kriulin, et al.
Published: (2019-11-01)

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management
by: Elena Elli, et al.
Published: (2012-03-01)

CASE PRESENTATION: TREATMENT AND FOLLOW-UP EXPERIENCE FROM MYELODYSPLASTIC SYNDROME (MDS) REAB II TO CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
by: Harika Shundo, et al.
Published: (2024-12-01)

Acute Myelomonocytic Leukemia Presenting as Perianal Pain
by: Syma Iqbal, et al.
Published: (2018-01-01)

The Thermodynamic and Gelation Properties of Ovalbumin and Lysozyme
by: Lifeng Wang, et al.
Published: (2025-06-01)

Refolding of Lysozyme Upon Interaction with ?-Cyclodextrin
by: G. Rezaei Behbehani
Published: (2011-06-01)

Effects of Hydrophobic Nanospaces on Structures of Lysozyme
by: Koki Takenaka, et al.
Published: (2015-01-01)

Safety evaluation of the food enzyme lysozyme from hens' eggs
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2023-04-01)

Safety evaluation of the food enzyme lysozyme from hens' eggs
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2023-03-01)

Nodal Mature Plasmacytoid Dendritic Cell Proliferation in a Patient With Chronic Myelomonocytic Leukemia: A Diagnostic Mimic of Blastic Plasmacytoid Dendritic Cell Neoplasm
by: Jowan Al-Nusair MD, et al.
Published: (2025-05-01)

Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia
by: Juwita Werner, et al.
Published: (2025-04-01)